Paper326381
Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial.
Fisher B and 19 others. Cancer, 1977. Cited by 342 papers, by iCite.
Cite this record
ConductScience Library. Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial. Papers, record 326381. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/326381
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial.
- PubMed
- Publication types
- Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Clinical Trials as Topic | |
| Female | |
| Humans | |
| Lymph Node Excision | |
| Mastectomy | |
| Middle Aged | |
| Neoplasm Metastasis | |
| Neoplasm Recurrence, Local | |
| Prospective Studies |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT05865964 | Anthropological, Socio-cultural and Psychological Surgeons' Factors in Oncology and Brakes for Evaluation of Innovations | Background |
Source ClinicalTrials.gov
Cited by84
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 342 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42608978 | Association between sentinel lymph node number and prognosis in cT1-2N0M0 early breast cancer patients with negative sentinel lymph nodes: a single‑center retrospective cohort study. | Ann Med | 2026 | https://conductscience.org/library/papers/42608978 | PubMed |
| 42488634 | Survival outcomes of axillary de-escalation following neoadjuvant chemo-immunotherapy in clinically node-positive triple-negative breast cancer: a national cancer database study. | Front Immunol | 2026 | https://conductscience.org/library/papers/42488634 | PubMed |
| 42299294 | Essentials for optimizing outcomes in oncoplastic breast reconstruction. | Gland Surg | 2026 | https://conductscience.org/library/papers/42299294 | PubMed |
| 42147263 | Omission of Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: Expanding Evidence in Clinically Node-Negative and Neoadjuvant Therapy Responders. | World J Oncol | 2026 | https://conductscience.org/library/papers/42147263 | PubMed |
| 42136760 | De-Escalation of Axillary Surgery: A Review of Choosing Wisely Guideline Evidence. | World J Oncol | 2026 | https://conductscience.org/library/papers/42136760 | PubMed |
| 41215861 | The chronologic history of post-mastectomy breast reconstructive surgery in the United Kingdom from 1975 to 2025. | Gland Surg | 2025 | https://conductscience.org/library/papers/41215861 | PubMed |
| 40976831 | De-escalating axillary surgery in node-positive early breast cancer patients undergoing primary surgery: current evidence and recommendations. | J Egypt Natl Canc Inst | 2025 | https://conductscience.org/library/papers/40976831 | PubMed |
| 40756954 | Omitting sentinel lymph node biopsy in early breast cancer: too bold or the future? | Transl Breast Cancer Res | 2025 | https://conductscience.org/library/papers/40756954 | PubMed |
| 40149336 | Impact of Axillary Burden on Survival: A Comparative Study of Invasive Lobular Carcinoma and Invasive Ductal Carcinoma in Early-Stage Breast Cancer. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40149336 | PubMed |
| 40103401 | Survival after standard or oncoplastic breast-conserving surgery versus mastectomy for breast cancer. | BJS Open | 2025 | https://conductscience.org/library/papers/40103401 | PubMed |
| 39941099 | The Role of Molecular Profiling in De-Escalation of Toxic Therapy in Breast Cancer. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/39941099 | PubMed |
| 39748531 | Radiation therapy volumes after primary systemic therapy in breast cancer patients: an international EUBREAST survey. | Radiat Oncol J | 2024 | https://conductscience.org/library/papers/39748531 | PubMed |
| 39717616 | The History of Breast Cancer Early Detection: 1865 - 2020. | Breast Cancer (Dove Med Press) | 2024 | https://conductscience.org/library/papers/39717616 | PubMed |
| 39610919 | Incidental discovery of invasive lobular carcinoma and anaplastic large cell lymphoma during sentinel lymph node biopsy: a case report. | Front Oncol | 2024 | https://conductscience.org/library/papers/39610919 | PubMed |
| 39031783 | Who still needs surgical staging of the axilla for invasive breast cancer? | J Surg Oncol | 2025 | https://conductscience.org/library/papers/39031783 | PubMed |
| 38534954 | Personalized Radiation Therapy for Breast Cancer. | Curr Oncol | 2024 | https://conductscience.org/library/papers/38534954 | PubMed |
| 38130814 | Locoregional Therapy: From Mastectomy to Reconstruction, Targeted Surgery, and Ultra-Hypofractionated Radiotherapy. | Breast Care (Basel) | 2023 | https://conductscience.org/library/papers/38130814 | PubMed |
| 37922004 | Optimising of axillary therapy in breast cancer: lessons from the past to plan for a better future. | Radiol Med | 2024 | https://conductscience.org/library/papers/37922004 | PubMed |
| 37324309 | Who Needs Level III Lymph Node Dissection in Carcinoma Breast-Study from a Tertiary Care Center. | Indian J Surg Oncol | 2023 | https://conductscience.org/library/papers/37324309 | PubMed |
| 36975448 | Safety and Accuracy of Sentinel Lymph Node Biopsy Alone in Clinically Node-Positive Patients Undergoing Upfront Surgery for Invasive Breast Cancer: A Systematic Review. | Curr Oncol | 2023 | https://conductscience.org/library/papers/36975448 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/326381
GET https://conductscience.org/api/papers/v1/326381/cited_by?page=2